1-(2,3-Dichlorophenyl)piperazine → HCID 11952878, compound
Reaction equation
[Cl:1][C:2]1[C:7]([Cl:8])=[CH:6][CH:5]=[CH:4][C:3]=1[N:9]1[CH2:14][CH2:13][NH:12][CH2:11][CH2:10]1.Cl[CH2:16][CH2:17][CH2:18][CH2:19][C:20]1[C:28]2[C:23](=[CH:24][CH:25]=[C:26]([F:29])[CH:27]=2)[NH:22][CH:21]=1>>[Cl:1][C:2]1[C:7]([Cl:8])=[CH:6][CH:5]=[CH:4][C:3]=1[N:9]1[CH2:14][CH2:13][N:12]([CH2:16][CH2:17][CH2:18][CH2:19][C:20]2[C:28]3[C:23](=[CH:24][CH:25]=[C:26]([F:29])[CH:27]=3)[NH:22][CH:21]=2)[CH2:11][CH2:10]1Participants
3
Procedure
from 1-(2,3-dichlorophenyl)piperazine and 3-(4-chlorobutyl)-5-fluoro-1H-indole. Mp 147–148° C. 1H NMR (DMSO-d6): 1.45–1.55 (m, 2H); 1.60–1.70 (m, 2H); 2.35 (t, 2H); 2.50 (b s, 4H); 2.65 (t, 2H); 2.95 (b s, 4H); 6.85–6.95 (m, 1H); 7.10–7.15 (m, 1H); 7.20 (s, 1H); 7.25–7.35 (m, 4H); 10.85 (b s, 1H). Ms m/z: 420 (MH+).
Sources & evidence
- ORD record
- ord-4102f90cc392469080b32fa2b0f6b712
- Source dataset
- uspto-grants-2007_05
- Patent number
- US07223765B2
Reaction notes
Loading…